Arcadia Biosciences (NASDAQ:RKDA) Share Price Passes Below Fifty Day Moving Average – Here’s What Happened

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report)’s share price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $5.15 and traded as low as $3.74. Arcadia Biosciences shares last traded at $3.81, with a volume of 2,146 shares traded.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Arcadia Biosciences in a research report on Thursday. They issued a “sell” rating for the company.

Get Our Latest Analysis on Arcadia Biosciences

Arcadia Biosciences Trading Up 4.1 %

The stock has a market capitalization of $5.20 million, a P/E ratio of -0.89 and a beta of 0.88. The stock’s 50 day simple moving average is $5.15 and its 200 day simple moving average is $4.04.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDAFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences at the end of the most recent quarter. 17.73% of the stock is currently owned by institutional investors and hedge funds.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Recommended Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.